NCT02775695 2023-07-03
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer
Medical College of Wisconsin
Phase 2 Completed
Clinical Trials
11 trialsNCT01874860 2022-12-01
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
University of Louisville
Phase 2 Completed
NCT02207556 2021-07-09
DUAL
Medical College of Wisconsin
Phase 2 Completed
NCT03448731 2020-04-08
DERMIA
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Completed
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT01847976 2019-09-06
OTT12-05
Ottawa Hospital Research Institute
Phase 2 Completed
NCT01465802 2019-01-09
ARCHER 1042
Pfizer
Phase 2 Completed
NCT02239731 2018-02-27
Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
Vyne Therapeutics Inc.
Phase 2 Completed
NCT01677286 2017-08-01
Safety and Effect of Doxycycline in Patients With Amyloidosis
Boston University
Phase 2 Completed
NCT01668498 2016-04-19
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
AIO-Studien-gGmbH
Phase 2 Completed
NCT01010295 2013-11-25
IELSG27
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed